Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Combination use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in diabetic kidney disease.

Combination use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in diabetic kidney disease. Curr Diab Rep. 2013 Aug; 13(4):567-73.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.